SCHEMBL15624005

SCHEMBL15624005

COc1ccc(F)c(F)c1-c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.47
FFAR1 O14842 3/20 0.46
SMN1; SMN2 Q16637 8/20 0.43
KDM4E B2RXH2 5/20 0.43
LMNA P02545 4/20 0.43
HTT P42858 3/20 0.43
POLB P06746 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MAPT P10636 2/20 0.42
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
PPP1CA P62136 2/20 0.42
CYP1A2 P05177 1/20 0.42
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
CCR8 P51685 1/20 0.42
METAP1 P53582 1/20 0.42
BLM P54132 1/20 0.42
HIF1A Q16665 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1207404 0.81 SYK (0.53) L3MBTL1FFAR1SMN1; SMN2KDM4ELMNA
SCHEMBL27912151 0.80 KDM4E (0.54) L3MBTL1FFAR1SMN1; SMN2KDM4ELMNA
SCHEMBL23039389 0.79 L3MBTL1 (0.44) L3MBTL1SMN1; SMN2KDM4EMAPTALDH1A1
SCHEMBL30895181 0.79 L3MBTL1 (0.44) L3MBTL1SMN1; SMN2KDM4EMAPTALDH1A1
SCHEMBL26260082 0.79 LMNA (0.48) L3MBTL1SMN1; SMN2KDM4ELMNAHTT
SCHEMBL5462166 0.78 SMN1; SMN2 (0.55) L3MBTL1FFAR1SMN1; SMN2KDM4ELMNA
SCHEMBL9815139 0.75 ALDH1A1 (0.58) L3MBTL1SMN1; SMN2KDM4ELMNAMAPT
SCHEMBL28004817 0.75 ERN1 (0.51) L3MBTL1SMN1; SMN2KDM4EMAPTALDH1A1
SCHEMBL15618043 0.72 APLNR (0.55) L3MBTL1FFAR1SMN1; SMN2KDM4ELMNA
SCHEMBL28180497 0.72 KDM4E (0.54) L3MBTL1FFAR1SMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424843-B1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2014-03-26 EP disclosed